Details of issuance or disposal
Monthly exercise status of the Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment terms)
Shares issued during the month: 10,000 new shares. Treasury shares transferred: 0 shares
The lower thin line represents the existing number of shares to which these shares will be added.
Exercise ratio during the month: 0.1% of the total 85,000 rights issued. Exercise ratio subject to exercise restrictions: 0.1%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment terms) |
| Number of shares to be issued or disposed of | Shares issued during the month: 10,000 new shares. Treasury shares transferred: 0 shares |
| Intended allottee | EVO FUND (issued on 12 December 2025) |
| Dilution Rate | Exercise ratio during the month: 0.1% of the total 85,000 rights issued. Exercise ratio subject to exercise restrictions: 0.1% |
| Total number of issued shares | As of the end of the month preceding the subject month: 13,506,001 shares (including 35,814 treasury shares) → Not disclosed |
| Exercise price | Exercise price during the month: ¥473; ¥494 to ¥455 on other days. Details of the adjustment provisions are Not disclosed in this disclosure |
| Number of Stock Acquisition Rights | Total rights issued: 85,000; exercised during the month: 100; unexercised at the end of the month preceding the subject month: 43,600; unexercised at month-end: 43,500 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 12 December 2025 / Type Eighth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in October 2026 for the Series 8 Stock Acquisition Rights issued on 12 December 2025.